KRAS and colorectal carcinoma: Interestingly, the PAK1/4-induced cell proliferation in KRAS-mutated CRC does not occur not through canonical the MEK/ERK or PI3K/AKT signaling pathway, but the anti-apoptotic signaling pathway via Bcl-2 and Bcl-X(L) [131].